Meletios A. Dimopoulos, Meral Beksac, Lotfi Benboubker, Huw Roddie, Nathalie Allietta, Esther Broer, Catherine Couturier, Marie-Andrée Mazier, Ralf Angermund, and Thierry Facon. 2013. “Phase II Study of bortezomib–dexamethasone Alone or With Added Cyclophosphamide or Lenalidomide for Sub-Optimal Response As Second-Line Treatment for Patients With Multiple Myeloma”. Haematologica 98 (8). Pavia, Italy, 1264-72.